Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients

Abstract At present, no study has established a survival prediction model for non-metastatic primary malignant bone tumors of the spine (PMBS) patients. The clinical features and prognostic limitations of PMBS patients still require further exploration. Data on patients with non-metastatic PBMS from...

Full description

Bibliographic Details
Main Authors: Yiming Shao, Zhonghao Wang, Xiaoya Shi, Yexin Wang
Format: Article
Language:English
Published: Nature Portfolio 2023-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-30509-y
_version_ 1797864778627022848
author Yiming Shao
Zhonghao Wang
Xiaoya Shi
Yexin Wang
author_facet Yiming Shao
Zhonghao Wang
Xiaoya Shi
Yexin Wang
author_sort Yiming Shao
collection DOAJ
description Abstract At present, no study has established a survival prediction model for non-metastatic primary malignant bone tumors of the spine (PMBS) patients. The clinical features and prognostic limitations of PMBS patients still require further exploration. Data on patients with non-metastatic PBMS from 2004 to 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Multivariate regression analysis using Cox, Best-subset and Lasso regression methods was performed to identify the best combination of independent predictors. Then two nomograms were structured based on these factors for overall survival (OS) and cancer-specific survival (CSS). The accuracy and applicability of the nomograms were assessed by area under the curve (AUC) values, calibration curves and decision curve analysis (DCA). Results: The C-index indicated that the nomograms of OS (C‐index 0.753) and CSS (C‐index 0.812) had good discriminative power. The calibration curve displays a great match between the model’s predictions and actual observations. DCA curves show our models for OS (range: 0.09–0.741) and CSS (range: 0.075–0.580) have clinical value within a specific threshold probability range compared with the two extreme cases. Two nomograms and web-based survival calculators based on established clinical characteristics was developed for OS and CSS. These can provide a reference for clinicians to formulate treatment plans for patients.
first_indexed 2024-04-09T22:57:46Z
format Article
id doaj.art-d824dfe838ce418eb8db527b6264d844
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T22:57:46Z
publishDate 2023-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-d824dfe838ce418eb8db527b6264d8442023-03-22T11:11:40ZengNature PortfolioScientific Reports2045-23222023-03-011311910.1038/s41598-023-30509-yDevelopment and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patientsYiming Shao0Zhonghao Wang1Xiaoya Shi2Yexin Wang3Department of Clinical Medicine, Jining Medical UniversityDepartment of Clinical Medicine, Jining Medical UniversityDepartment of Oncology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Spine Surgery, Affiliated Hospital of Jining Medical UniversityAbstract At present, no study has established a survival prediction model for non-metastatic primary malignant bone tumors of the spine (PMBS) patients. The clinical features and prognostic limitations of PMBS patients still require further exploration. Data on patients with non-metastatic PBMS from 2004 to 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Multivariate regression analysis using Cox, Best-subset and Lasso regression methods was performed to identify the best combination of independent predictors. Then two nomograms were structured based on these factors for overall survival (OS) and cancer-specific survival (CSS). The accuracy and applicability of the nomograms were assessed by area under the curve (AUC) values, calibration curves and decision curve analysis (DCA). Results: The C-index indicated that the nomograms of OS (C‐index 0.753) and CSS (C‐index 0.812) had good discriminative power. The calibration curve displays a great match between the model’s predictions and actual observations. DCA curves show our models for OS (range: 0.09–0.741) and CSS (range: 0.075–0.580) have clinical value within a specific threshold probability range compared with the two extreme cases. Two nomograms and web-based survival calculators based on established clinical characteristics was developed for OS and CSS. These can provide a reference for clinicians to formulate treatment plans for patients.https://doi.org/10.1038/s41598-023-30509-y
spellingShingle Yiming Shao
Zhonghao Wang
Xiaoya Shi
Yexin Wang
Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
Scientific Reports
title Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
title_full Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
title_fullStr Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
title_full_unstemmed Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
title_short Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
title_sort development and validation of nomograms predicting overall and cancer specific survival for non metastatic primary malignant bone tumor of spine patients
url https://doi.org/10.1038/s41598-023-30509-y
work_keys_str_mv AT yimingshao developmentandvalidationofnomogramspredictingoverallandcancerspecificsurvivalfornonmetastaticprimarymalignantbonetumorofspinepatients
AT zhonghaowang developmentandvalidationofnomogramspredictingoverallandcancerspecificsurvivalfornonmetastaticprimarymalignantbonetumorofspinepatients
AT xiaoyashi developmentandvalidationofnomogramspredictingoverallandcancerspecificsurvivalfornonmetastaticprimarymalignantbonetumorofspinepatients
AT yexinwang developmentandvalidationofnomogramspredictingoverallandcancerspecificsurvivalfornonmetastaticprimarymalignantbonetumorofspinepatients